The Sanofi Group
The ambition of Sanofi is to become a diversified global healthcare leader, focused on patients’ needs.
The largest pharmaceutical company in Europe and in emerging markets, Sanofi is the fourth largest worldwide. The Group’s vaccine division, sanofi pasteur, is the world leader for human vaccine production and commercialization.
With nearly 100,000 employees in over 100 countries, Sanofi has core strengths in the field of healthcare: a worldwide presence, market leadership in vaccines, major biological products and a strong and long-established presence in emerging markets.
Sanofi can draw on a number of powerful assets to address the new context in the global pharmaceutical market: an extensive portfolio of prescription medicines, vaccines, generics medicines, consumer health care and animal health, along with a balanced presence on both traditional and emerging markets.
Great medicines for millions of patients
Sanofi addresses fundamental health issues and makes major therapeutic solutions available in its areas of expertise: oncology, diabetes, thrombotic and cardiovascular diseases and central nervous system disorders.
Vaccines: Sanofi Pasteur, the vaccines division of Sanofi, provided more than 1.6 billion doses of vaccine in 2009, allowing the vaccination of more than 500 million people worldwide. A global leader in vaccines, sanofi pasteur offers the broadest range of vaccines protecting against 20 infectious diseases.
Updated March 31, 2010
